{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:47:03Z","timestamp":1791010023440,"version":"4.1.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The nebulization of amphotericin B desoxycholate (AMB-DOC), liposomal amphotericin B (L-AMB), amphotericin B lipid complex (ABLC) and amphotericin B colloidal dispersion (ABCD) has been investigated. Particle sizes of generated aerosol droplets were measured. Pulmonary amphotericin B deposition and amphotericin B concentration in blood directly after nebulization and at six weeks after nebulization was measured in healthy rats. The efficacy of nebulized amphotericin B formulations was evaluated in persistently granulocytopenic rats with invasive pulmonary aspergillosis. Treatment was given either after or before fungal inoculation. The endpoint was survival of animals. Aerosol particle sizes, expressed as the values for the mass median diameter were 1.38, 2.43, 0.90 and 2.29 \u03bcm for AMB-DOC, L-AMB, ABLC and ABCD, respectively. Amphotericin B concentrations in the lungs directly after nebulization exceeded the minimum inhibitory concentration of Aspergillus fumigatus and amphotericin B was still detected in lungs of rats at six weeks after nebulization. Treatment, started at 16 h after fungal inoculation, resulted in a significantly prolonged survival as compared with sham-treated rats for all four formulations. Prophylactic treatment at one week before fungal inoculation resulted in a significantly prolonged survival for all four formulations. Aerosol treatment given at two weeks before inoculation was effective only for AMB-DOC and L-AMB, whereas treatment given at six weeks resulted in a significantly prolonged survival for L-AMB only. All commercially available amphotericin B preparations could be nebulized efficiently and may be of value in the prophylactic treatment of invasive pulmonary aspergillosis.<\/jats:p>","DOI":"10.1211\/jpp.57.10.0007","type":"journal-article","created":{"date-parts":[[2005,10,7]],"date-time":"2005-10-07T22:42:46Z","timestamp":1128724966000},"page":"1289-1295","source":"Crossref","is-referenced-by-count":35,"title":["Nebulization of four commercially available amphotericin B formulations in persistently granulocytopenic rats with invasive pulmonary aspergillosis: evidence for long-term biological activity"],"prefix":"10.1093","volume":"57","author":[{"given":"Elisabeth J","family":"Ruijgrok","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology & Infectious Diseases, Erasmus University Medical Center Rotterdam , Dr. Molewaterplein 40, 3015 GD, Rotterdam,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel H A","family":"Fens","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology & Infectious Diseases, Erasmus University Medical Center Rotterdam , Dr. Molewaterplein 40, 3015 GD, Rotterdam,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma A J M","family":"Bakker-Woudenberg","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology & Infectious Diseases, Erasmus University Medical Center Rotterdam , Dr. Molewaterplein 40, 3015 GD, Rotterdam,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Els W M","family":"Van Etten","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology & Infectious Diseases, Erasmus University Medical Center Rotterdam , Dr. Molewaterplein 40, 3015 GD, Rotterdam,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth J","family":"Ruijgrok","sequence":"additional","affiliation":[{"name":"Hospital Pharmacy, Erasmus University Medical Center Rotterdam , Dr. Molewaterplein 40, 3015 GD, Rotterdam,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold G","family":"Vulto","sequence":"additional","affiliation":[{"name":"Hospital Pharmacy, Erasmus University Medical Center Rotterdam , Dr. Molewaterplein 40, 3015 GD, Rotterdam,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,10,1]]},"reference":[{"key":"2024103109413540300_cit1","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/jac\/34.6.1001","article-title":"Prophylactic efficacy of aerosolised liposomal (AmBisome) and non-liposomal (Fungizone) amphotericin B in murine pulmonary aspergillosis","volume":"34","author":"Allen","year":"1994","journal-title":"J. Antimicrob. Chemother."},{"key":"2024103109413540300_cit2","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1128\/AAC.22.6.1042","article-title":"Therapeutic activities of cefazolin, cefotaxime, and ceftazidime against experimentally induced Klebsiella pneumoniae in rats","volume":"22","author":"Bakker-Woudenberg","year":"1982","journal-title":"Antimicrob. Agents Chemother."},{"key":"2024103109413540300_cit3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0195-6701(88)90220-4","article-title":"The emergence of fungi as major hospital pathogens","volume":"11","author":"Bodey","year":"1988","journal-title":"J. Hospital Infect."},{"key":"2024103109413540300_cit4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1128\/AAC.41.2.259","article-title":"Efficacy of prophylactic aerosol amphotericin B lipid complex in a rat model of pulmonary aspergillosis","volume":"41","author":"Cicogna","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"2024103109413540300_cit5","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1086\/513943","article-title":"Invasive aspergillosis","volume":"26","author":"Denning","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"2024103109413540300_cit6","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/BF01726364","article-title":"Tolerance and efficacy of amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in haematological patients","volume":"16","author":"Erjavec","year":"1997","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"2024103109413540300_cit7","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/clinids\/12.2.308","article-title":"Amphotericin B: 30 years of clinical experience","volume":"12","author":"Gallis","year":"1990","journal-title":"Rev. Infect. Dis."},{"key":"2024103109413540300_cit8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF01695915","article-title":"Low incidence of invasive fungal infection after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia","volume":"68","author":"Hertenstein","year":"1994","journal-title":"Ann. Hematol."},{"key":"2024103109413540300_cit9","volume-title":"Inhalation aerosols \u2014 physical and biological basis for therapy.","author":"Hickey","year":"1996"},{"key":"2024103109413540300_cit10","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1021\/js9604218","article-title":"Disposition of aerosolized amphotericin B","volume":"86","author":"Lambros","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"2024103109413540300_cit11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/jac\/38.2.215","article-title":"Liposomal amphotericin B (Ambisome) reduces dissemination of infection as compared to amphotericin B deoxycholate (Fungizone) in a newly developed animal model of one-sided pulmonary aspergillosis","volume":"38","author":"Leenders","year":"1996","journal-title":"J. Antimicrob. Chemother."},{"key":"2024103109413540300_cit12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1365-2141.1998.00944.x","article-title":"Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections","volume":"103","author":"Leenders","year":"1998","journal-title":"Br. J. Haematol."},{"key":"2024103109413540300_cit13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/jac\/43.2.267","article-title":"Risk factors for amphotericin B-induced nephrotoxicity","volume":"43","author":"Luber","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"2024103109413540300_cit14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003495-200161001-00002","article-title":"Current management of fungal infections","volume":"61","author":"Meis","year":"2001","journal-title":"Drugs"},{"key":"2024103109413540300_cit15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1211\/0022357001774417","article-title":"Aerosol delivery of amphotericin B desoxycholate (Fungizone) and liposomal amphotericin B (AmBisome): Aerosol characteristics and in-vivo deposition in rats","volume":"52","author":"Ruijgrok","year":"2000","journal-title":"J. Pharm. Pharmacol."},{"key":"2024103109413540300_cit16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/jac\/48.1.89","article-title":"Aerosolised amphotericin B desoxycholate and liposomal amphotericin B: efficacy in the treatment of invasive pulmonary aspergillosis in severely immunocompromised rats and in-vivo effect on surfactant function","volume":"48","author":"Ruijgrok","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"2024103109413540300_cit17","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1128\/AAC.32.11.1676","article-title":"Aerosol amphotericin B is effective for prophylaxis and therapy in a rat model of invasive pulmonary aspergillosis","volume":"32","author":"Schmitt","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"2024103109413540300_cit18","first-page":"3654","article-title":"Aerosolized amphotericin B inhalations as prophylaxis of invasive Aspergillus infections during prolonged neutropenia: results of a prospective randomized multicenter trial","volume":"11","author":"Schwartz","year":"1999","journal-title":"Blood"},{"key":"2024103109413540300_cit19","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/jac\/35.4.509","article-title":"Biodistribution of liposomal amphotericin B (AmBisome\u00ae) and amphotericin B desoxycholate (Fungizone\u00ae) in uninfected immu-nocompetent mice and granulocytopenic mice infected with Candida albicans","volume":"35","author":"Van Etten","year":"1995","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1211%2Fjpp.57.10.0007","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/57\/10\/1289\/60261553\/jpp.57.10.0007.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/57\/10\/1289\/60261553\/jpp.57.10.0007.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T21:29:52Z","timestamp":1736026192000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/57\/10\/1289\/6147633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,1]]},"references-count":19,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2005,10,1]]},"published-print":{"date-parts":[[2005,10,1]]}},"URL":"https:\/\/doi.org\/10.1211\/jpp.57.10.0007","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2005,10]]},"published":{"date-parts":[[2005,10,1]]}}}